MRD / Regn No. : SG004612 Date : 23/06/2026
Patient Name : J Nandi Age & Gender : 72 Yrs. / Male
Contact No. : 7003322898 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (23/Jun/2026) | MASLD (23/Jun/2026) | HYPERTENSION (23/Jun/2026) |
Subjective : COUGH,FEVERISH
Salient Investigations : ALT ALANINE AMINOTRANSFERASE: 76 IU/L | CREATININE: 1 | EGFR EGLOMERULAR FILTRATION RATE: 78.25 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 193 mg/dL | HB HEMOGLOBIN: 10.3 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 15 % | LDL LOW DENSITY LIPOPROTEIN: 47 mg/dL | MICROALBUMIN CREATININE RATIO: 119.7 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 227 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ATORVASTATIN 20 MG
TONACT 20 MG
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
2 AMLODIPINE 5 MG + TELMISARTAN 40 MG
TAZLOC AM
1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + SITAGLIPTIN 100 MG + METFORMIN 500 MG
LUPISIT DM 500
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
4 CUFUROXIME 500 MG
CETIL
PO 1-0-1 BEFORE BREAKFAST AND DINNER
10 DAYS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 23/Dec/2026
Tests Suggested For Next Visit : CHECK FASTING AND PP AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,CREATININE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: